Cd20-negative diffuse large b-cell lymphoma subtype: a look at texas cancer registry

by Kartik Anand, Allyne M. Ensor, Joe E. Ensor
Published 2020-09-01

Distinct epidemiological profiles associated with inflammatory breast cancer (IBC): A comprehensive analysis of the IBC registry at The University of Texas MD Anderson Cancer Cente...

by Tamer M Fouad, Naoto T Ueno, Robert K Yu, Joe E Ensor, Ricardo H Alvarez, Savitri Krishnamurthy, Anthony Lucci, James M Reuben, Wei Yang, Jie S Willey, Vicente Valero, Melissa L Bondy, Massimo Cristofinalli, Sanjay Shete, Wendy A Woodward, Randa El-Zein
Published 2018-01-01

A randomized, controlled phase II trial of neoadjuvant ado-trastuzumab emtansine, lapatinib, and nab-paclitaxel versus trastuzumab, pertuzumab, and paclitaxel in HER2-positive brea...

by Tejal A. Patel, Joe E. Ensor, Sarah L. Creamer, Toniva Boone, Angel A. Rodriguez, Poly A. Niravath, Jorge G. Darcourt, Jane L. Meisel, Xiaoxian Li, Jing Zhao, John G. Kuhn, Roberto R. Rosato, Wei Qian, Anna Belcheva, Mary R. Schwartz, Virginia G. Kaklamani, Jenny C. Chang
Published 2019-09-01

HN1L Promotes Triple-Negative Breast Cancer Stem Cells through LEPR-STAT3 Pathway

by Yi Liu, Dong Soon Choi, Jianting Sheng, Joe E. Ensor, Diana Hwang Liang, Cristian Rodriguez-Aguayo, Amanda Polley, Steve Benz, Olivier Elemento, Akanksha Verma, Yang Cong, Helen Wong, Wei Qian, Zheng Li, Sergio Granados-Principal, Gabriel Lopez-Berestein, Melissa D. Landis, Roberto R. Rosato, Bhuvanesh Dave, Stephen Wong, Dario Marchetti, Anil K. Sood, Jenny C. Chang
Published 2018-01-01